5-Year Postoperative Outcomes of Patients Who Completed the CREST Study
Public ClinicalTrials.gov record NCT07480343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
FIVE-YEAR POSTOPERATIVE OUTCOMES IN PATIENTS WITH OPEN-ANGLE GLAUCOMA WHO UNDERWENT BIO-INTERVENTIONAL UVEOSCLERAL OUTFLOW ENHANCEMENT SURGERY: LONG-TERM OBSERVATIONAL FOLLOW-UP FROM THE CREST STUDY (THE CREST-XT STUDY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to collect clinical data at 3, 4, and 5 years postoperatively for participants who completed the CREST Study without having secondary IOP-lowering surgery in the study eye(s).
Study identification
- NCT ID
- NCT07480343
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
- CycloPen Micro-Interventional Cyclodialysis System Procedure
- CycloPen Micro-Interventional Cyclodialysis System Post Cataract Procedure
Procedure
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 15, 2025 (Actual)
- Primary completion
- Dec 2030 (Estimated)
- Completion
- Dec 2030 (Estimated)
- Last update posted
- Jul 21, 2026
2025 – 2030
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CREST-XT Site 05 | Newport Beach | California | 92663 | — |
| CREST-XT Site 03 | Cape Coral | Florida | 33904 | — |
| CREST-XT Site 10 | DeLand | Florida | 32720 | — |
| CREST-XT Site 07 | Atlanta | Georgia | 30342 | — |
| CREST-XT Site 12 | Chevy Chase | Maryland | 20815 | — |
| CREST-XT Site 13 | Rockville | Maryland | 20852 | — |
| CREST-XT Site 16 | Las Vegas | Nevada | 89145 | — |
| CREST-XT Site 01 | Fort Washington | Pennsylvania | 19034 | — |
| CREST-XT Site 04 | Crossville | Tennessee | 38555 | — |
| CREST-XT Site 11 | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07480343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 21, 2026 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07480343 live on ClinicalTrials.gov.